Arcellx Appoints Neeraj Teotia as Chief Commercial Officer
Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it has hired Neeraj Teotia has been named Chief Commercial Officer where he will have responsibility for marketing, sales, and health economics and reimbursement.
Mr. Teotia joins Arcellx with more than 20 years of experience in the healthcare industry. Most recently he served as the Vice President of Marketing at Nevro where he and his team set and helped execute commercial plans for a rapidly growing business that grew over 10x during his tenure. His responsibilities included product and clinical portfolio strategy, branding, demand generation, key thought leader engagement, professional education, sales forecasting and analytics, sales management, sales training, and market access. Prior to Nevro, Mr. Teotia worked at Johnson & Johnson where he had various roles of increasing responsibility within Marketing, Licensing & Acquisitions and Research & Development. Mr. Teotia received an M.B.A. from the Kellogg School of Management at Northwestern University and has a B.S. in Electrical Engineering from the University of Illinois at Urbana-Champaign.
About Arcellx, Inc.
Arcellx is a clinical-stage biopharmaceutical company developing adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. The Arcellx vision is to utilize our novel proprietary platform to bring superior cell therapies to more patients through the care of academic and community practices worldwide. More information can be found at www.arcellx.com.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.